Author:
Ravandi Farhad,Giles Francis
Reference196 articles.
1. McCulloch. EA. Stem cells in normal and leukemic hemopoiesis. Blood 1983;62(1):1–13.
2. Estey EH, Thall PF. New designs for phase 2 clinical trials. Blood 2003;102:442–448.
3. Parker WB, Shaddix SC, Chang CH, et al. Effects of 2-chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl) adenine on K562 cellular metabolism and the inhibition of human ribonucleotide reductase and DNA polymerases by its 5′-triphosphate. Cancer Res 1991;51:2386–2394.
4. Kantarjian HM, Gandhi V, Kozuch P, et al. Phase I clinical and pharmacology study of clofarabine in patients with solid and hematological cancers. J Clin Oncol 2003;21:1167–1173.
5. Kantarjian HM, Gandhi V, Cortes J, et al. Phase II clinical and pharmacology study of clofarabine in patients with refractory or relapsed acute leukemia. Blood 2003